Vildagliptin, a dipeptidyl peptidase-4 inhibitor, reduces betel-nut induced carcinogenesis in female mice
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 266, 118870
Abstract
No abstract availableKeywords
Funding Information
- DBT (BT/567/NE/U-Excel/2016)
This publication has 66 references indexed in Scilit:
- Areca nut chewing and metabolic syndrome: evidence of a harmful relationshipNutrition Journal, 2013
- Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registryBreast Cancer Research and Treatment, 2013
- Effects of betel nut on cardiovascular risk factors in a rat modelBMC Cardiovascular Disorders, 2012
- Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow upBMC Cancer, 2012
- Factors affecting commencement and cessation of betel quid chewing behaviour in Malaysian adultsBMC Public Health, 2011
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell GrowthCell Metabolism, 2008
- Liver lipid metabolismJournal of Animal Physiology and Animal Nutrition, 2008
- Phosphorylation of the PTEN Tail Acts as an Inhibitory Switch by Preventing Its Recruitment into a Protein ComplexJournal of Biological Chemistry, 2001
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976